Earlier this year, the Department of Defense released two annual reports on the status of its chemical and biological defense efforts (both pdf):
“Department of Defense Chemical and Biological Defense Program,” Annual Report to Congress, April 2007.
“Report on Activities and Programs for Countering Proliferation and NBC Terrorism,” Counterproliferation Program Review Committee, Volume I, Executive Summary, May 2007.
To secure the U.S. bio-infrastructure, maintain global leadership in biotechnology, and safeguard American citizens from emerging threats to their privacy, the federal government must modernize its approach to human genetic and biological data.
To ensure an energy transition that brings broad based economic development, participation, and direct benefits to communities, we need federal policy that helps shape markets. Unfortunately, there is a large gap in understanding of how to leverage federal policy making to support access to capital and credit.
From use to testing to deployment, the scaffolding for responsible integration of AI into high-risk use cases is just not there.
OPM’s new HR 2.0 initiative is entering hostile terrain. Those who have followed federal HR modernization for years desperately want this effort to succeed.